Cargando…
Intravenous Methylprednisolone Pulse Therapy Versus Intravenous Immunoglobulin in the Prevention of Coronary Artery Disease in Children with Kawasaki Disease: A Randomized Controlled Trial
Background: Kawasaki disease (KD) is often complicated by coronary artery lesion (CAL), including dilatation or aneurysms. Intravenous immunoglobulin (IVIG) is used with aspirin to prevent CAL in KD. Objective: Given that the primary treatment for other vasculitis is the use of corticosteroids, this...
Autores principales: | Aslani, Nahid, Raeeskarami, Seyed-Reza, Aghaei-Moghadam, Ehsan, Tahghighi, Fatemeh, Assari, Raheleh, Sadeghi, Payman, Ziaee, Vahid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312282/ https://www.ncbi.nlm.nih.gov/pubmed/35911298 http://dx.doi.org/10.7759/cureus.26252 |
Ejemplares similares
-
Methylprednisolone pulses as an initial treatment in hyperinflammatory syndrome after COVID-19 in children: evaluation of laboratory data, serial echocardiography and outcome: a case series
por: Sadeghi, Payman, et al.
Publicado: (2022) -
Multisystem inflammatory syndrome in children and Kawasaki disease; comparison of their clinical findings and one-year follow-up—a cross-sectional study
por: Mehrban, Saghar, et al.
Publicado: (2023) -
Intravenous immunoglobulin for the treatment of Kawasaki disease
por: Broderick, Cathryn, et al.
Publicado: (2023) -
Impact of Early Treatment With High-Dose Intravenous Immunoglobulin on Incidence of Kawasaki Disease Complications in Iranian Children
por: Karimi Yazdi, Alireza, et al.
Publicado: (2021) -
Increased QT Interval Dispersion is Associated with Coronary Artery Involvement in Children with
Kawasaki Disease
por: Moghadam, Ehsan Aghaei, et al.
Publicado: (2020)